Metabolic syndrome and serum carotenoids: Findings of a cross-sectional study in Queensland, Australia

British Journal of Nutrition

Volumn 102, Issue 11, 2009, Pages 1668-1677

  Coyne, Terry ^a   Ibiebele, Torukiri I ^b   Baade, Peter D ^c,d   McClintock, Christine S ^a   Shaw, Jonathan E ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Carotenoids; Cross sectional studies; Metabolic syndrome

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; CAROTENOIDS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; QUEENSLAND; SMOKING; SOCIOECONOMIC FACTORS;

EID: 73749087255     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450999081X     Document Type: Article

References (42)

1. Wilson W, D'Agostino R, Parise H, et al. (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066-3072.
2. Dekker J, Girman C, Rhodes T, et al. (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112, 666-673.
3. Ford E, Giles W & Dietz W (2002) Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356-359.
4. Ruhe RC & McDonald RB (2001) Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20, 363S-369S, discussion 81S-83S.
5. Ford ES, Will JC, Bowman BA, et al. (1999) Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149, 168-176.
6. Coyne T, Ibiebele T, Baade P, et al. (2005) Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 82, 685-693.
7. Suzuki K, Ito Y, Nakamura S, et al. (2002) Relationship between serum carotenoids and hyperglycemia: a populationbased cross-sectional study. J Epidemiol 12, 357-366.
8. Hozawa A, Jacobs DR, Steffes MW, et al. (2006) Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study. Clin Chem 53, 447-455.
9. D'Odorico A, Martines D, Kiechl S, et al. (2000) High plasma levels of alpha-and beta-carotene are associated with a lower risk of atherosclerosis. Results from the Bruneck Study. Atherosclerosis 153, 231-239.
10. Ito Y, Suzuki K, Ishii J, et al. (2006) A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac J Cancer Prev 7, 533-546.
11. Daviglus ML, Orencia AJ, Dyer AR, et al. (1997) Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. Neuroepidemiology 16, 69-77.
12. Hozawa A, Jacobs DR Jr, Steffes MW, et al. (2009) Circulating carotenoid concentrations and incident hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Hypertens 27, 237-242.
13. Giovannucci E, Rimm EB, Liu Y, et al. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391-398.
14. D'Odorico A, Bortolan S, Cardin R, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36, 1289-1294.
15. Brazionis L, Rowley K, Itsiopoulos C, et al. (2008) Plasma carotenoids and diabetic retinopathy. Br J Nutr 13, 1-8.
16. Eitenmiller RR & Landen WO (editors) (1999) Vitamin Analysis for the Health and Food Sciences. Boca Raton, FL: CRC Press.
17. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. (2007) Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 85, 910-918.
18. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. (2006) Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 84, 1489-1497.
19. Ford ES, Mokdad AH, Giles WH, et al. (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52, 2346-2352.
20. Yoo S, Nicklas T, Baranowski T, et al. (2004) Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr 80, 841-848.
21. Lutsey PL, Steffen LM & Stevens J (2008) Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities Study. Circulation 117, 754-761. (Pubitemid 351640676)
22. Liu S, Ajani U, Chae C, et al. (1999) Long-term beta-carotene supplementation and risk of type2 diabetes mellitus: a randomised controlled trial. JAMA 282, 1073-1075.
23. Ford E, Mokdad A, Giles W, et al. (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes Care 2, 2346-2352. (Pubitemid 37059506)
24. Sugiura M, Nakamura M, Ogawa K, et al. (2008) Associations of serum carotenoid concentrations with the metabolic syndrome: interaction with smoking. Br J Nutr 29, 1-10.
25. Dunstan DW, Zimmet PZ, Welborn TA, et al. (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25, 829-834.
26. Dunstan DW, Zimmet PZ, Welborn TA, et al. (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diabetes Res Clin Pract 57, 119-129.
27. Friedewald WT, Levy R & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
28. Talwar D, Ha TK, Cooney J, et al. (1998) A routine method for the simultaneous measurement of retinol, alpha-tocopherol and five carotenoids in human plasma by reverse phase HPLC. Clin Chim Acta 270, 85-100.
29. Alberti K, Zimmet PZ & Shaw JE (2006) Metabolic syndrome-a new world-wide definition. A concensus statement from the International Diabetes Federation. Diabet Med 23, 469-480.
30. Stata Corporation (2003) Stata/SE Statistical Software: Release 8.0 for Windows. College Station, TX: Stata Corporation.
31. Andersen LF, Jacobs DR Jr, Gross MD, et al. (2006) Longitudinal associations between body mass index and serum carotenoids: the CARDIA Study. Br J Nutr 95, 358-365.
32. Coyne T, Ibiebele TI, McNaughton S, et al. (2005) Evaluation of brief dietary questions to estimate vegetable and fruit consumption-using serum carotenoids and red-cell folate. Public Health Nutr 8, 298-308.
33. Millen BE, Pencina MJ, Kimokoti RW, et al. (2006) Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 84, 434-441.
34. Dietrich M, Block G, Norkus EP, et al. (2003) Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 77, 160-166.
35. Hozawa A, Jacobs DR Jr, Steffes MW, et al. (2006) Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163, 929-937.
36. Redon J, Oliva M, Tormos C, et al. (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096-1101.
37. Furukawa S, Fujita T, Shimabukuro M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761.
38. Hansel B, Giral P, Nobecourt E, et al. (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89, 4963-4971.
39. Montonen J, Knekt P, Jarvinen R, et al. (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27, 362-366.
40. Sargent L, Khaw K, Bingham S, et al. (2001) Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. Eur J Clin Nutr 55, 342-348.
41. Tuomilehto J, Lindstrom J, Eriksson J, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 344, 1343-1350. (Pubitemid 32378388)
42. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 346, 393-403.